Regions Financial Corp’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$325K Sell
2,583
-106
-4% -$13.3K ﹤0.01% 693
2025
Q1
$297K Buy
2,689
+100
+4% +$11.1K ﹤0.01% 691
2024
Q4
$353K Sell
2,589
-35
-1% -$4.78K ﹤0.01% 651
2024
Q3
$302K Sell
2,624
-543
-17% -$62.6K ﹤0.01% 703
2024
Q2
$436K Sell
3,167
-18
-0.6% -$2.48K ﹤0.01% 600
2024
Q1
$439K Sell
3,185
-155
-5% -$21.4K ﹤0.01% 617
2023
Q4
$440K Sell
3,340
-125
-4% -$16.5K ﹤0.01% 614
2023
Q3
$390K Sell
3,465
-120
-3% -$13.5K ﹤0.01% 606
2023
Q2
$338K Sell
3,585
-69
-2% -$6.51K ﹤0.01% 669
2023
Q1
$370K Sell
3,654
-215
-6% -$21.8K ﹤0.01% 658
2022
Q4
$462K Sell
3,869
-50
-1% -$5.97K ﹤0.01% 602
2022
Q3
$416K Sell
3,919
-168
-4% -$17.8K ﹤0.01% 609
2022
Q2
$398K Buy
4,087
+484
+13% +$47.1K ﹤0.01% 643
2022
Q1
$338K Buy
3,603
+877
+32% +$82.3K ﹤0.01% 725
2021
Q4
$232K Sell
2,726
-434
-14% -$36.9K ﹤0.01% 846
2021
Q3
$303K Buy
3,160
+70
+2% +$6.71K ﹤0.01% 760
2021
Q2
$301K Sell
3,090
-1,412
-31% -$138K ﹤0.01% 752
2021
Q1
$437K Buy
4,502
+63
+1% +$6.12K ﹤0.01% 608
2020
Q4
$425K Sell
4,439
-18
-0.4% -$1.72K ﹤0.01% 595
2020
Q3
$429K Buy
4,457
+1
+0% +$96 ﹤0.01% 558
2020
Q2
$544K Buy
4,456
+1,055
+31% +$129K 0.01% 511
2020
Q1
$295K Buy
3,401
+307
+10% +$26.6K ﹤0.01% 592
2019
Q4
$333K Buy
3,094
+60
+2% +$6.46K ﹤0.01% 644
2019
Q3
$273K Sell
3,034
-33
-1% -$2.97K ﹤0.01% 675
2019
Q2
$259K Buy
3,067
+90
+3% +$7.6K ﹤0.01% 705
2019
Q1
$262K Buy
2,977
+688
+30% +$60.6K ﹤0.01% 706
2018
Q4
$164K Buy
2,289
+1,005
+78% +$72K ﹤0.01% 821
2018
Q3
$158K Sell
1,284
-10
-0.8% -$1.23K ﹤0.01% 894
2018
Q2
$127K Buy
+1,294
New +$127K ﹤0.01% 952